Trials / Withdrawn
WithdrawnNCT00506610
A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Flexible Escalating -Dose, Pilot Analgesic Efficacy Study of T-62 in Subjects With Postherpetic Neuralgia
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether T-62 is effective in providing relief of pain that can occur after an individual experiences a shingles outbreak, which is an infection in adults caused by the same virus that causes chicken pox.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | T-62 |
Timeline
- First posted
- 2007-07-25
- Last updated
- 2012-06-07
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00506610. Inclusion in this directory is not an endorsement.